Abrocitinib versus dupilumab: impact on skin barrier function and proteomics in atopic dermatitis
{{output}}
Background: The comparative impact of dupilumab and abrocitinib on skin barrier function and associated proteomics in atopic dermatitis (AD) remains not fully identified. ... ...
